The long-running legal battle centred around UWA’s claims that it owned the majority of the company’s IP portfolio because the company’s SIR sphere technology was developed by Gray while he was employed by the university.
Background:
Dr Gray was appointed as a Professor of Surgery by UWA in 1985. He had previously conducted research into cancer treatment, and this research was further developed at UWA and became the subject of three patent families. The patents were subsequently assigned to Sirtex Medical Ltd in exchange for shares in the company. Dr Gray’s terms of employment by UWA required him to teach and to conduct research. He was also obliged to comply with obligations under the UWA statutes.
The Federal Court ruled against the university in April 2008 in a landmark decision (subsequently upheld on appeal to the Full Bench of the Federal Court, in September 2009), which found UWA’s case did not have a legal foundation for the following reasons:
The University has now finally exhausted their legal options, with the High Court refusing to hear a further appeal.
UWA vice chancellor Professor Alan Robson said “the university was disappointed by the decision, as it left the relationship between universities and research institutes and the intellectual property their staff developed “ill-defined”. "The university's course of action was a matter of principle that had important ramifications for the protection of intellectual property and the flow-on benefits of university-initiated research to the broader community,” Professor Robson said.
"Expressions of concern about the potential ramifications of this case have been received from research institutions around the world. "This could have extremely important ramifications for research, not only in universities but at other research organisations, in Australia and around the world."
It should be emphasised that there were complex, possibly unique, circumstances in this particular case (the Federal Court decision of French J was over 600 pages long). In particular, UWA had employed a researcher who had already begun developing the field of technology prior to his time at UWA, and did not appear to have an IP Policy which was integrated with employment contracts, or mechanisms to identify and capture IP developed by employees.
In the modern era where universities and research institutes are becoming more commercially focused, there are some important lessons to be learned from the decision in relation to management of intellectual assets.
We understand that, in addition to seeking leave from the High Court to appeal the case, the university took action last year to try to compel its staff to sign IP agreements before receiving research funding.
Aspects of this report were sourced from Nick Evans, Editor of Biotechnology News, and Roger Green’s news article.
Dr Bruce Dowsing